-
-
-
-
-
-
-
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
-
-
-
-
-
-
-
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Pulmatrix (PULM) Reports Q1 Loss of $1.22
-
-
-
-
-
-
-
Pulmatrix (PULM) Reports Q1 Revenue of $1.2M, EPS of ($1.51)
-
-
-
-
-
-
-
Pulmatrix Reports Third Quarter 2020 Financial Results and Business Updates
-
-
-
-
-
-
-
Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
-
-
-
-
-
-
-
Pulmatrix Reports Q2 2016 Financial Results
-
1,219,395 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

